Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by StockscoutXon Jun 30, 2021 5:12pm
218 Views
Post# 33474976

RE:But the REAL news...

RE:But the REAL news...Only $17+ million for 2021? I was expecting much more. Furthermore, not really new news at AGM as much of what is known is already baked into the SP. Now, it's obvious why the AGM was scheduled on june 30 a day before the canadian stock markets are closed. Also, Tripp was barely voted as a director which there will be more of the same going forward. As for the reverse split 2:1, it was a wise decision because the stock market would not have taken the news kindly to it if it was approved. As for the SP going forward, lots of sideways and maybe dip lower if nothing new comes out of StageZero.

gojotv! wrote: For "those with eyes to see and ears to hear..." as the good book says...
is that the reverse split won't happen. Even management decided against it.
And we all know that the main reason given for it was an uplisting to the NASDAQ... for which we need a higher share price.
And we all know that the main thing necessary to raise the share price is an increase in revenues...
And we all know that Rebecca called our eResearch analyst's revenue estimate of 17M for 2021 "conservative".
I'm clearly not the only one who can put together the pieces here, because the share price is rising.
GLTA!


<< Previous
Bullboard Posts
Next >>